Literature DB >> 7684301

Support of renal blood flow after ischaemic-reperfusion injury by endogenous formation of nitric oxide and of cyclo-oxygenase vasodilator metabolites.

J P Cristol1, C Thiemermann, J A Mitchell, C Walder, J R Vane.   

Abstract

1. Ischaemia-reperfusion injury in the kidney is associated with a loss of autoregulation, an increase in renal vascular resistance (RVR), a decrease of renal blood flow (RBF) and ultimately acute renal failure. The aim of this study was to investigate the role of the release of endogenous nitric oxide (NO) in the recovery of RBF after ischaemic injury of the renal vascular bed. 2. Anaesthetized rats (thiopentone sodium; 120 mg kg-1, i.p.) were submitted to acute renal ischaemia followed by 2 or 6 h of reperfusion (I/R). Reperfusion was associated with a significant reduction in RBF, an increase in RVR, and an impairment of the vasodilator effect of acetylcholine (ACh). 3. NG-nitro-L-arginine methyl ester (L-NAME, 30 micrograms kg-1 min-1, i.v., n = 5) significantly prevented the recovery of RBF after I/R injury. Similarly, inhibition of prostanoid formation with indomethacin (5 mg kg-1, i.v., n = 4) significantly enhanced the rise in RVR associated with I/R injury. 4. Infusion of L-arginine (L-Arg; 1 or 3 mg kg-1 min-1, i.v., n = 5 and 4, respectively) or D-Arg (1 mg kg-1 min-1, i.v., n = 6), starting 30 min after occlusion, did not improve the recovery of RBF. Furthermore, infusion of L-Arg (20 mg kg-1 min-1 for 15 min; n = 4) had no effect on the I/R-induced impairment of the vasodilator responses to ACh. 5. To elucidate the relative importance of the constitutive and inducible NO synthase isoforms for the formation of NO after I/R, calcium-dependent (constitutive) and calcium-independent (inducible) NO synthase activities were measured in kidney homogenates obtained from ischaemic or non-ischaemic kidneys. A calcium-independent NO synthase activity was not detectable in kidney homogenates obtained from either sham-operated control rats or from animals subjected to I/R. Moreover, dexamethasone(3 mg kg-1, i.v., 60 min prior to I/R, n = 6), an inhibitor of the induction of NO synthase,had no effect on either RBF or RVR in rats subjected to I/R. In contrast to I/R, lipopolysaccaride(LPS, endotoxin; 5 mg kg-1, i.p., n = 3) caused a significant induction of a calcium-independent NO synthase activity in the kidney.6. These results confirm the importance of the release of vasodilator cyclo-oxygenase metabolites in the compromised renal circulation and indicate that the formation of NO derived from the constitutive, but not the inducible NO synthase, is also important for the maintenance of RBF after I/R injury of the renal vascular bed.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 7684301      PMCID: PMC2175578          DOI: 10.1111/j.1476-5381.1993.tb13552.x

Source DB:  PubMed          Journal:  Br J Pharmacol        ISSN: 0007-1188            Impact factor:   8.739


  45 in total

1.  Hemodynamic aspects in development and recovery phases of experimental postischemic acute renal failure.

Authors:  M Kashgarian; N J Siegel; A L Ries; H J DiMeola; J P Hayslett
Journal:  Kidney Int Suppl       Date:  1976-10       Impact factor: 10.545

2.  Role of intracellular thiols in release of EDRF from cultured endothelial cells.

Authors:  M Hecker; I Siegle; H Macarthur; W C Sessa; J R Vane
Journal:  Am J Physiol       Date:  1992-03

3.  Differential inhibitory action of phorbol-12,13-dibutyrate on the positive inotropic effect of endothelin-1 and Bay K 8644 in the isolated rabbit papillary muscle.

Authors:  M Endoh; M Takanashi
Journal:  J Cardiovasc Pharmacol       Date:  1991       Impact factor: 3.105

4.  Endogenous endothelium-derived relaxing factor opposes hypoxic pulmonary vasoconstriction and supports blood flow to hypoxic alveoli in anesthetized rabbits.

Authors:  R S Sprague; C Thiemermann; J R Vane
Journal:  Proc Natl Acad Sci U S A       Date:  1992-09-15       Impact factor: 11.205

5.  Impaired endothelium-dependent relaxation of dog coronary arteries after myocardial ischaemia and reperfusion: prevention by amlodipine, propranolol and allopurinol.

Authors:  C G Sobey; R A Dalipram; G J Dusting; O L Woodman
Journal:  Br J Pharmacol       Date:  1992-03       Impact factor: 8.739

Review 6.  Current concepts on the pathophysiology of acute renal failure.

Authors:  J H Stein; M D Lifschitz; L D Barnes
Journal:  Am J Physiol       Date:  1978-03

7.  NG-hydroxy-L-arginine prevents the haemodynamic effects of nitric oxide synthesis inhibition in the anaesthetized rat.

Authors:  C E Walder; C Thiemermann; J R Vane
Journal:  Br J Pharmacol       Date:  1992-10       Impact factor: 8.739

Review 8.  Secretory functions of the vascular endothelium.

Authors:  J R Vane; R M Botting
Journal:  J Physiol Pharmacol       Date:  1992-09       Impact factor: 3.011

9.  Selective inhibition of agonist-induced but not shear stress-dependent release of endothelial autacoids by thapsigargin.

Authors:  H Macarthur; M Hecker; R Busse; J R Vane
Journal:  Br J Pharmacol       Date:  1993-01       Impact factor: 8.739

10.  Effect of L-NG-nitro-arginine, inhibitor of nitric oxide synthesis, on autoregulation of renal blood flow in dogs.

Authors:  H Kiyomoto; H Matsuo; T Tamaki; Y Aki; H Hong; H Iwao; Y Abe
Journal:  Jpn J Pharmacol       Date:  1992-02
View more
  10 in total

1.  RGS4, a GTPase activator, improves renal function in ischemia-reperfusion injury.

Authors:  Andrew M Siedlecki; Xiaohua Jin; Winston Thomas; Keith A Hruska; Anthony J Muslin
Journal:  Kidney Int       Date:  2011-03-16       Impact factor: 10.612

2.  Nitric oxide in ischaemic acute renal failure of streptozotocin diabetic rats.

Authors:  Y Goor; G Peer; A Iaina; M Blum; Y Wollman; T Chernihovsky; D Silverberg; S Cabili
Journal:  Diabetologia       Date:  1996-09       Impact factor: 10.122

Review 3.  Role of medullary blood flow in the pathogenesis of renal ischemia-reperfusion injury.

Authors:  Kevin R Regner; Richard J Roman
Journal:  Curr Opin Nephrol Hypertens       Date:  2012-01       Impact factor: 2.894

4.  Endotoxic shock after long-term resuscitation of hemorrhage/reperfusion injury decreased splanchnic blood flow and eicosanoid release.

Authors:  S I Myers; R H Tumage; K M Kadesky; A R Seelig; L Bartula
Journal:  Ann Surg       Date:  1996-08       Impact factor: 12.969

5.  Glibenclamide-induced inhibition of the expression of inducible nitric oxide synthase in cultured macrophages and in the anaesthetized rat.

Authors:  C C Wu; C Thiemermann; J R Vane
Journal:  Br J Pharmacol       Date:  1995-03       Impact factor: 8.739

Review 6.  Renal endothelial dysfunction in acute kidney ischemia reperfusion injury.

Authors:  David P Basile; Mervin C Yoder
Journal:  Cardiovasc Hematol Disord Drug Targets       Date:  2014

7.  Low-dose testosterone protects against renal ischemia-reperfusion injury by increasing renal IL-10-to-TNF-α ratio and attenuating T-cell infiltration.

Authors:  Chetan N Patil; Kedra Wallace; Babbette D LaMarca; Mohadetheh Moulana; Arnaldo Lopez-Ruiz; Andrea Soljancic; Luis A Juncos; Joseph P Grande; Jane F Reckelhoff
Journal:  Am J Physiol Renal Physiol       Date:  2016-06-01

8.  Attenuation of ischemia-reperfusion injury by ascorbic acid in the canine renal transplantation.

Authors:  Jae-il Lee; Hwa-Young Son; Myung-cheol Kim
Journal:  J Vet Sci       Date:  2006-12       Impact factor: 1.672

9.  Preventive Role of Endothelin Antagonist on Kidney Ischemia: Reperfusion Injury in Male and Female Rats.

Authors:  Nazgol Esmalian Afyouni; Hanieh Halili; Fatemeh Moslemi; Mehdi Nematbakhsh; Ardeshir Talebi; Soheila Shirdavani; Maryam Maleki
Journal:  Int J Prev Med       Date:  2015-12-23

10.  Genetic Deletion of Vasohibin-2 Exacerbates Ischemia-Reperfusion-Induced Acute Kidney Injury.

Authors:  Hiromasa Miyake; Katsuyuki Tanabe; Satoshi Tanimura; Yuri Nakashima; Tomoyo Morioka; Kana Masuda; Hitoshi Sugiyama; Yasufumi Sato; Jun Wada
Journal:  Int J Mol Sci       Date:  2020-06-26       Impact factor: 5.923

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.